# A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.

> **NCT00436124** · PHASE4 · TERMINATED · sponsor: **Hoffmann-La Roche**

## Conditions studied

- Influenza

## Interventions

- **DRUG:** oseltamivir [Tamiflu]

## Key facts

- **NCT ID:** NCT00436124
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** — (—)
- **Why stopped:** poor recruitment, no patients were enrolled
- **Last updated:** 2017-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00436124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00436124, "A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00436124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*